Cite
HARVARD Citation
Prabhu, V. et al. (2017). Cost-effectiveness of ceftolozane/tazobactam plus metronidazole compared with piperacillin/tazobactam as empiric therapy for the treatment of complicated intra-abdominal infections based on the in-vitro surveillance of bacterial isolates in the UK. Journal of medical economics. pp. 840-849. [Online].